Claritas Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	2015
Period Ending	Mar '25 Mar 31, 2025	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	2015
Market Capitalization	0	1	19	13	49	-	Upgrade
Market Cap Growth	13841.99%	-97.16%	43.59%	-72.44%	-	-	Upgrade
Enterprise Value	-	1	20	17	48	-	Upgrade
Last Close Price	0.00	0.02	0.74	0.95	7.45	-	Upgrade
PE Ratio	0.00	0.13	-	1.93	-	-	Upgrade
PB Ratio	0.00	0.36	-5.59	1.37	-4.17	-	Upgrade
EV/EBIT Ratio	-	5.17	-	-	-	-	Upgrade
Debt / Equity Ratio	0.16	0.61	-0.21	0.03	-0.25	-	Upgrade
Quick Ratio	0.01	0.03	0.03	0.10	0.95	2.54	Upgrade
Current Ratio	1.43	0.14	0.03	0.10	0.95	2.54	Upgrade
Return on Equity (ROE)	65.09%	-	-670.52%	-	-	-688.15%	Upgrade
Return on Assets (ROA)	2.77%	0.64%	-13.92%	-11.11%	-8.57%	-116.25%	Upgrade
Return on Capital (ROIC)	8.69%	-	-161.63%	-1114.66%	-	-188.84%	Upgrade
Return on Capital Employed (ROCE)	14.70%	5.50%	-	-	-	-	Upgrade
Earnings Yield	-12415789.47%	770.96%	-110.41%	51.83%	-65.63%	-	Upgrade
FCF Yield	-	-56.59%	-33.74%	-36.23%	-11.45%	-	Upgrade
Buyback Yield / Dilution	-33.44%	-18.94%	-105.55%	-75.89%	-322.12%	-39.75%	Upgrade

Updated Nov 29, 2021. Source: S&P Global Market Intelligence. Standard template. Financial Sources.